IBDEI0IS ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8453,1,3,0)
 ;;=3^Need to Immediately Re-Void
 ;;^UTILITY(U,$J,358.3,8453,1,4,0)
 ;;=4^R39.191
 ;;^UTILITY(U,$J,358.3,8453,2)
 ;;=^5139199
 ;;^UTILITY(U,$J,358.3,8454,0)
 ;;=R39.192^^39^398^73
 ;;^UTILITY(U,$J,358.3,8454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8454,1,3,0)
 ;;=3^Micturition,Position Dependent
 ;;^UTILITY(U,$J,358.3,8454,1,4,0)
 ;;=4^R39.192
 ;;^UTILITY(U,$J,358.3,8454,2)
 ;;=^5139200
 ;;^UTILITY(U,$J,358.3,8455,0)
 ;;=R97.21^^39^398^103
 ;;^UTILITY(U,$J,358.3,8455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8455,1,3,0)
 ;;=3^Rising PSA After Tx for Prostate CA
 ;;^UTILITY(U,$J,358.3,8455,1,4,0)
 ;;=4^R97.21
 ;;^UTILITY(U,$J,358.3,8455,2)
 ;;=^5139228
 ;;^UTILITY(U,$J,358.3,8456,0)
 ;;=N50.82^^39^398^104
 ;;^UTILITY(U,$J,358.3,8456,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8456,1,3,0)
 ;;=3^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,8456,1,4,0)
 ;;=4^N50.82
 ;;^UTILITY(U,$J,358.3,8456,2)
 ;;=^5138930
 ;;^UTILITY(U,$J,358.3,8457,0)
 ;;=N50.812^^39^398^108
 ;;^UTILITY(U,$J,358.3,8457,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8457,1,3,0)
 ;;=3^Testicular Pain,Left Side
 ;;^UTILITY(U,$J,358.3,8457,1,4,0)
 ;;=4^N50.812
 ;;^UTILITY(U,$J,358.3,8457,2)
 ;;=^5138928
 ;;^UTILITY(U,$J,358.3,8458,0)
 ;;=N50.811^^39^398^109
 ;;^UTILITY(U,$J,358.3,8458,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8458,1,3,0)
 ;;=3^Testicular Pain,Right Side
 ;;^UTILITY(U,$J,358.3,8458,1,4,0)
 ;;=4^N50.811
 ;;^UTILITY(U,$J,358.3,8458,2)
 ;;=^5138927
 ;;^UTILITY(U,$J,358.3,8459,0)
 ;;=N35.919^^39^398^114
 ;;^UTILITY(U,$J,358.3,8459,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8459,1,3,0)
 ;;=3^Urethral Stricture,NOS,Male
 ;;^UTILITY(U,$J,358.3,8459,1,4,0)
 ;;=4^N35.919
 ;;^UTILITY(U,$J,358.3,8459,2)
 ;;=^5157412
 ;;^UTILITY(U,$J,358.3,8460,0)
 ;;=N35.92^^39^398^113
 ;;^UTILITY(U,$J,358.3,8460,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8460,1,3,0)
 ;;=3^Urethral Stricture,NOS,Female
 ;;^UTILITY(U,$J,358.3,8460,1,4,0)
 ;;=4^N35.92
 ;;^UTILITY(U,$J,358.3,8460,2)
 ;;=^5157413
 ;;^UTILITY(U,$J,358.3,8461,0)
 ;;=R82.81^^39^398^101
 ;;^UTILITY(U,$J,358.3,8461,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8461,1,3,0)
 ;;=3^Pyuria
 ;;^UTILITY(U,$J,358.3,8461,1,4,0)
 ;;=4^R82.81
 ;;^UTILITY(U,$J,358.3,8461,2)
 ;;=^101879
 ;;^UTILITY(U,$J,358.3,8462,0)
 ;;=N18.30^^39^398^17
 ;;^UTILITY(U,$J,358.3,8462,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8462,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3 Unspec
 ;;^UTILITY(U,$J,358.3,8462,1,4,0)
 ;;=4^N18.30
 ;;^UTILITY(U,$J,358.3,8462,2)
 ;;=^5159286
 ;;^UTILITY(U,$J,358.3,8463,0)
 ;;=N18.31^^39^398^18
 ;;^UTILITY(U,$J,358.3,8463,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8463,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3a
 ;;^UTILITY(U,$J,358.3,8463,1,4,0)
 ;;=4^N18.31
 ;;^UTILITY(U,$J,358.3,8463,2)
 ;;=^5159287
 ;;^UTILITY(U,$J,358.3,8464,0)
 ;;=N18.32^^39^398^19
 ;;^UTILITY(U,$J,358.3,8464,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8464,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3b
 ;;^UTILITY(U,$J,358.3,8464,1,4,0)
 ;;=4^N18.32
 ;;^UTILITY(U,$J,358.3,8464,2)
 ;;=^5159288
 ;;^UTILITY(U,$J,358.3,8465,0)
 ;;=G44.1^^39^399^10
 ;;^UTILITY(U,$J,358.3,8465,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8465,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,8465,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,8465,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,8466,0)
 ;;=G43.909^^39^399^6
